Microbial transformation of capsaicin by several human intestinal fungi and their inhibitory effects against lysine-specific demethylase 1. (October 2022)

• Record Type: Journal Article
• Authors: Deng, Ying; Wang, Yan; Huo, Xiaokui; Deng, Sa; Jin, Lingling; Zhang, Houli; Yu, Zhenlong; Ning, Jing; Ma, Xiaochi; Wang, Chao
• Is Part Of: Phytochemistry. Volume 202(2022)
• Publication Date: 2022-10
• Subjects: Capsaicin -- Biotransformation -- Intestinal fungi -- Lysine-specific demethylase 1; Botanical chemistry -- Periodicals; Biochemistry -- Periodicals; Botany -- Periodicals; Chimie végétale -- Périodiques; 572.2
• DOI: 10.1016/j.phytochem.2022.113365
• Languages: English
• ISSNs: 0031-9422

Abstract

Abstract: Capsaicin widely exists in the Capsicum genus (e.g., hot peppers) and is commonly used as a food additive or medicinal material. In this work, microbial transformation of capsaicin was performed based on the three cultivated human intestinal fungi. Fourteen metabolites were obtained, and their chemical structures were elucidated by spectroscopic data analysis, including 13 compounds with undescribed structures. Hydroxylation, lactylation, succinylation, citric acylation, and acetylation were observed for these microbial metabolites derived from capsaicin, which indicated diverse catalytic characteristics of human intestinal fungi. In an in vitro bioassay, four metabolites and capsaicin inhibited the activity of lysine-specific demethylase 1 (LSD1) with a more than 70% inhibitory rate at 10 μM. In particular, 9, 5′-dihydroxycapsaicin displayed the strongest inhibitory effect with an IC50 of 1.52 μM. Therefore, capsaicin analogs displayed potential application as LSD1 inhibitors against the invasion and migration of cancer cells. Graphical abstract: The microbial transformation of capsaicin afforded 14 metabolites, some of which could inhibit LSD1 significantly. Image 1 Highlights: The microbial transformation of capsaicin was performed by several human intestinal fungi. 14 metabolites were obtained from the biotransformation of capsaicin. 13 undescribed structures were determined for the metabolites of capsaicin. Several capsaicin analogs could inhibit LSD1 significantly at 10 μM.